These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17047260)

  • 1. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).
    Nishio T; Kunieda E; Shirato H; Ishikura S; Onishi H; Tateoka K; Hiraoka M; Narita Y; Ikeda M; Goka T
    Phys Med Biol; 2006 Nov; 51(21):5409-17. PubMed ID: 17047260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0702).
    Nishio T; Shirato H; Ishikawa M; Miyabe Y; Kito S; Narita Y; Onimaru R; Ishikura S; Ito Y; Hiraoka M
    J Radiat Res; 2014 May; 55(3):600-7. PubMed ID: 24385469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
    Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
    Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric verification and clinical evaluation of a new commercially available Monte Carlo-based dose algorithm for application in stereotactic body radiation therapy (SBRT) treatment planning.
    Fragoso M; Wen N; Kumar S; Liu D; Ryu S; Movsas B; Munther A; Chetty IJ
    Phys Med Biol; 2010 Aug; 55(16):4445-64. PubMed ID: 20668343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program.
    Dunlap N; McIntosh A; Sheng K; Yang W; Turner B; Shoushtari A; Sheehan J; Jones DR; Lu W; Ruchala K; Olivera G; Parnell D; Larner JL; Benedict SH; Read PW
    Med Dosim; 2010; 35(4):312-9. PubMed ID: 21055611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group-Radiation Therapy Study Group.
    Nishio T; Nakamura M; Okamoto H; Kito S; Minemura T; Ozawa S; Kumazaki Y; Ishikawa M; Tohyama N; Kurooka M; Nakashima T; Shimizu H; Suzuki R; Ishikura S; Nishimura Y
    J Radiat Res; 2020 Nov; 61(6):999-1008. PubMed ID: 32989445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion.
    Kanagaki B; Read PW; Molloy JA; Larner JM; Sheng K
    Phys Med Biol; 2007 Jan; 52(1):243-55. PubMed ID: 17183139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT.
    Mendes R; Lavrenkov K; Bedford JL; Henrys A; Ashley S; Brada M
    Radiother Oncol; 2006 Mar; 78(3):322-5. PubMed ID: 16564591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
    Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.
    Matsuo Y; Takayama K; Nagata Y; Kunieda E; Tateoka K; Ishizuka N; Mizowaki T; Norihisa Y; Sakamoto M; Narita Y; Ishikura S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):416-25. PubMed ID: 17363190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric evaluation of a conformal seven-field coplanar technique for planning lung stereotactic body radiotherapy.
    Richmond N; Green J; Peedell C; Shakespeare D; Walker C
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e24-30. PubMed ID: 21763114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group.
    Nagata Y; Hiraoka M; Mizowaki T; Narita Y; Matsuo Y; Norihisa Y; Onishi H; Shirato H
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):343-7. PubMed ID: 19735861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lung and target density on small-field dose coverage and PTV definition.
    Higgins PD; Ehler ED; Cho LC; Dusenbery KE
    Med Dosim; 2015; 40(1):16-20. PubMed ID: 25155213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
    Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
    Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.